If Epichem was fit for purpose surely they could have made the new MPL tablets in house. if producing the tablets for their parent company was too costly then what hope did they have competing in the market at large. Perhaps too many PHDs and not enough doers.
Ann: Epichem enters voluntary liquidation, page-126
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.1M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 22.0¢ | $89.24K | 403.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 142257 | 3 |
View Market Depth
| Last trade - 15.52pm 17/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |